Company profile for Protara Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. We are a diverse team of entrepreneurs, scientists and veteran rare disease and biopharma specialists, dedicated to our mission of disco...
Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. We are a diverse team of entrepreneurs, scientists and veteran rare disease and biopharma specialists, dedicated to our mission of discovering, developing and delivering breakthrough therapies to people who have limited treatment options.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1 Little West 12th Street New York, NY 10014
Telephone
Telephone
+1 646-844-0337
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/08/3201966/0/en/Protara-Announces-Closing-of-75-Million-Public-Offering.html

GLOBENEWSWIRE
08 Dec 2025

https://www.globenewswire.com/news-release/2025/12/04/3200349/0/en/Protara-Announces-Proposed-Public-Offering.html

GLOBENEWSWIRE
04 Dec 2025

https://www.globenewswire.com/news-release/2025/12/01/3197457/0/en/Protara-Therapeutics-to-Host-Conference-Call-and-Webcast-to-Review-New-Interim-Data-from-Phase-2-ADVANCED-2-Trial-of-TARA-002-in-BCG-Na%C3%AFve-NMIBC-Patients-on-Wednesday-December-3-20.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/19/3190887/0/en/Protara-Therapeutics-Announces-Positive-Interim-Results-Demonstrating-Robust-Responses-in-the-Ongoing-Phase-2-STARBORN-1-Trial-of-TARA-002-in-Pediatric-Patients-with-Lymphatic-Malf.html

GLOBENEWSWIRE
19 Nov 2025

https://www.globenewswire.com/news-release/2025/11/18/3190507/0/en/Protara-Therapeutics-to-Host-Conference-Call-and-Webcast-to-Review-New-Interim-Data-from-Phase-2-STARBORN-1-Trial-of-TARA-002-in-Pediatric-Patients-with-Lymphatic-Malformations-on-.html

GLOBENEWSWIRE
18 Nov 2025

https://www.globenewswire.com/news-release/2025/11/17/3189070/0/en/Protara-Therapeutics-to-Present-New-Interim-Data-from-Phase-2-ADVANCED-2-Trial-of-TARA-002-in-BCG-Na%C3%AFve-NMIBC-Patients-at-the-26th-Annual-Meeting-of-the-Society-of-Urologic-Oncolog.html

GLOBENEWSWIRE
17 Nov 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty